Treatment with pLDLR-LDLR-miR82 in this further short-term study resulted in a lipid lowering of ~50% as compared to uninjected animals, demonstrating the efficacy of this vector even in an extreme hypercholesterolaemic FH model (Supplementary Figure S4a). The gene discussed is LDLR; the disease is familial hyperaldosteronism.